The Senate committee on Wednesday examined the nomination of Dr. Erica Schwartz to lead the Centers for Disease Control and Prevention, a position that has seen rapid turnover and significant workforce depletion since the Trump administration took office in January 2025.
Schwartz, 54, previously oversaw the U.S. Coast Guard’s network of 41 clinics and 150 sick bays and later served as deputy surgeon general. President Trump nominated her in April. The agency she would now direct has lost more than 3,000 employees—roughly a quarter of its total workforce—in the past 18 months, according to personnel records.
A History of Turnover at the CDC
The CDC has experienced unprecedented instability in its leadership. Dr. David Weldon’s Senate confirmation hearing for the director position was canceled just one hour before it was scheduled to begin in March 2025. Susan Monarez was confirmed as director but was removed from the role in less than a month. Jay Bhattacharya, director of the National Institutes of Health, has most recently overseen CDC operations.
Health Secretary Robert F. Kennedy Jr., who chairs the agency, has been instrumental in the department’s restructuring efforts.
Schwartz’s Background and Financial Interests
Schwartz filed her required financial disclosure letters last month, revealing employment with UnitedHealth Group, where she earned approximately $850,000 in salary and bonus compensation. Her nomination as CDC director comes alongside that of Sean Kaufman for Assistant Secretary for Preparedness and Response.
Staffing Crisis and Its Impact
The exodus of CDC personnel has raised concerns about the agency’s capacity to function. Dr. David Margolius, director of the Cleveland health department, acknowledged the challenge facing the remaining workforce. “There’s still really good people who work there,” Margolius said. “They are doing their best to navigate choppy waters.”
The staffing losses have also shifted how public health guidance flows across the country. Margolius observed that without a fully functional national coordinating body, local health departments operate with greater independence. “Basically everybody’s got to kind of choose their own adventure, as opposed to being led by a national public health department,” he said.
What Comes Next
Schwartz’s confirmation by the full Senate would stabilize the CDC director position and provide permanent leadership as the agency continues its restructuring. The Senate committee’s review will likely examine her qualifications, her management experience, and her vision for the agency’s priorities under Kennedy’s oversight.
The CDC’s turmoil reflects broader efforts by the Trump administration to reshape federal health agencies. These changes align with the stated goals of the Make America Healthy Again movement to reform agency operations and reorient federal health policy, though the rapid departures have created operational disruptions that local and state health officials continue to manage.
For Idaho, where the state Department of Health and Welfare coordinates with federal CDC guidance on disease surveillance and public health preparedness, the appointment of stable CDC leadership may clarify the lines of communication and policy direction that have been unclear during the transition period.